GlassScriptPhysician profile
Samuel P Robinson
NPI 1912134131
$5,376.18
in general payments reported to CMS, 2019-2025
41 companies · $641 in 2025
The $641 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,034 · 2020: $278 · 2021: $1,315 · 2022: $656 · 2023: $929 · 2024: $522 · 2025: $641.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,992 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,992.26 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $695.09 | 2019-2024 | Xtandi |
| Abbvie INC. | $640.20 | 2019-2025 | Botox, Lupron Depot |
| Pfizer INC. | $411.24 | 2019-2025 | |
| Myriad Genetic Laboratories, INC. | $393.12 | 2023-2025 | Prolaris |
| Janssen Biotech, INC. | $341.05 | 2019-2025 | Erleada |
| Boston Scientific Corporation | $337.34 | 2021-2025 | Spaceoar System |
| Bayer Healthcare Pharmaceuticals INC. | $217.17 | 2020-2024 | |
| Accord Healthcare, INC. | $215.00 | 2022-2023 | |
| Medtronic, INC. | $206.65 | 2023-2024 | Interstim |
| Endo Pharmaceuticals INC. | $199.02 | 2019-2022 | |
| Ambu INC. | $194.07 | 2021-2024 | |
| Amgen INC. | $140.88 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $132.64 | 2023-2025 | Orgovyx, Gemtesa |
| Blue Earth Diagnostics | $121.33 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $118.56 | 2022-2025 | Lynparza, Keytruda |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $110.29 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $78.38 | 2020-2025 | Lynparza |
| Integra Lifesciences Corporation | $67.19 | 2021 | |
| Antares Pharma, INC. | $66.15 | 2019-2021 | |
| Dendreon Pharmaceuticals LLC | $63.17 | 2019-2022 | |
| Travere Therapeutics, INC. | $62.86 | 2019-2022 | |
| Allergan, INC. | $62.71 | 2019-2021 | |
| Urogen Pharma, INC. | $62.66 | 2021-2022 | |
| Coloplast Corp | $57.88 | 2023 | Porges Coloplast |
| Rochester Medical Corporation | $38.45 | 2021 | |
| Agiliti Surgical, INC. | $38.44 | 2024-2025 | Sonablate Hifu, Soltive Superpulsed Laser, Koelis Trinity Fusion Biopsy System |
| Alnylam Pharmaceuticals INC. | $35.41 | 2021 | |
| Dornier Medtech America, INC | $33.65 | 2020 | |
| Tolmar Pharmaceuticals, INC. | $33.10 | 2019-2020 | |
| Olympus America INC. | $31.68 | 2022-2025 | Itind System |
| Dentsply Ih Ab | $20.64 | 2025 | Lofric |
| Ferring Pharmaceuticals INC. | $18.53 | 2019 | |
| Urovant Sciences INC | $16.62 | 2022 | |
| Endo USA, INC. | $16.34 | 2024 | Xiaflex |
| Verity Pharmaceuticals INC. | $16.12 | 2023 | Trelstar |
| Calyxo, INC. | $15.90 | 2024 | Cvac Aspiration System |
| Therapeuticsmd, INC. | $15.78 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.58 | 2023 | |
| Angiodynamics, INC. | $13.09 | 2023 | Nanoknife |
| Clarus Therapeutics INC. | $12.15 | 2021 | |
| Mission Pharmacal Company | $12.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.